Tg(tetO-lacZ,-SHANK2_iA*,-Venus)2Rsp
Transgene Detail
|
Symbol: |
Tg(tetO-lacZ,-SHANK2_iA*,-Venus)2Rsp |
Name: |
transgene insertion 2, Rolf Sprengel |
MGI ID: |
MGI:7567843 |
Synonyms: |
TgSHANK2A(R462X) |
Transgene: |
Tg(tetO-lacZ,-SHANK2_iA*,-Venus)2Rsp Location: unknown
|
Alliance: |
Tg(tetO-lacZ,-SHANK2_iA*,-Venus)2Rsp page
|
|
Strain of Origin: |
C57BL6/N
|
|
Transgene Type: |
|
Transgenic (Inducible, Inserted expressed sequence, Reporter) |
Inducer: |
|
tamoxifen |
Mutation: |
|
Insertion
|
|
|
Tg(tetO-lacZ,-SHANK2_iA*,-Venus)2Rsp expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
SHANK2 (22941) |
|
|
|
|
|
Mutation details: The transgene contains a bi-directional tetracycline-responsive promoter element controlling the expression of the nuclear-localized beta-galactosidase (nLacZ) on one side and fusion transcript composed of green fluorescent protein variant (Venus), fused via the ribosomal skipping sequence T2A to the brain-specific isoform (A) of the human gene with the mutation responsible for the amino acid substitution of arginine with a stop codon at position 462 (R462*).
(J:310967)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:310967 Eltokhi A, et al., Imbalanced post- and extrasynaptic SHANK2A functions during development affect social behavior in SHANK2-mediated neuropsychiatric disorders. Mol Psychiatry. 2021 May 21; |
All: |
1 reference(s) |
|